documents: FDA-2011-N-0583-0016

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2011-N-0583-0016 FDA FDA-2011-N-0583 Clarification of Orphan-Drug Exclusivity Following Catalyst Pharms., Inc. v. Becerra; Notification Rule Approval 2023-01-24T05:00:00Z 2023 1 2023-01-24T05:00:00Z   2023-01-24T17:14:45Z 2023-01179 0 0 0900006485606066

Links from other tables